首页> 美国卫生研究院文献>Heart Lung and Vessels >Remifentanil to treat hypertension in overweight patients during a fentanyl-based cardiac anesthesia A case series
【2h】

Remifentanil to treat hypertension in overweight patients during a fentanyl-based cardiac anesthesia A case series

机译:瑞芬太尼用于基于芬太尼的心脏麻醉期间超重患者的高血压治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac surgery is associated with intense nociceptive and autonomic stimulation especially during sternotomy and aortic root dissection and moderate-to-high dose opioids are required to blunt the hemodynamic and neuroendocrine response to this kind of procedures. However, episodes of unwanted sympathetic activation leading to intraoperative hypertension are not always preventable with a fentanyl-based anesthesia regimen and antihypertensive drugs without anesthetic properties are added to obtain hemodynamic stability. We report on five cardiac surgical cases in which intraoperative hypertension unresponsive to incremental doses of fentanyl was successfully treated adding a remifentanil target-controlled infusion instead of a non-anesthetic vasoactive drug. This approach could help to avoid the dilemma: when should we stop adding anesthetics and switch to antihypertensive drugs in cardiac surgery? 
机译:心脏手术与强烈的伤害性和自主神经刺激相关,尤其是在胸骨切开术和主动脉根部解剖期间,需要中高剂量的阿片类药物来钝化对此类手术的血流动力学和神经内分泌反应。然而,使用基于芬太尼的麻醉方案并不能始终预防导致交往性高血压的不良交感神经激活现象,并且添加了无麻醉特性的降压药以获得血液动力学稳定性。我们报告了五例心脏外科手术病例,其中术中对芬太尼递增剂量无反应的高血压被成功治疗,加入了瑞芬太尼靶标控制的输注而不是非麻醉性血管活性药物。这种方法可以帮助避免两难选择:在心脏外科手术中,什么时候应该停止添加麻醉剂并改用降压药?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号